Clearing the Way in Atopic Dermatitis A Case-Based Update on Pediatric Patients

Jacob P. Thyssen, MD, PhD, DmSci


This activity is jointly provided by Global Education Group and Integritas Communications. 


This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.


Jacob P. Thyssen, MD, PhD, DmSci
Department of Dermatology and Venereology
Bispebjerg Hospital
University of Copenhagen
Copenhagen, Denmark

Program Description

This Interactive Professor™activity is designed to educate pediatric dermatologists, dermatologists, and allergists/immunologists involved in the ongoing management of pediatric patients with moderate-to-severe atopic dermatitis. Using a case-based, question and answer approach, an international faculty expert will walk through the initial evaluation of Anders, a 10-year-old boy from Denmark, discuss comorbidities, previous treatments, new and emerging therapies for pediatric patients and individualizing treatment using a shared decision-making approach.

Target Audience

The educational design of this activity addresses the needs of pediatric dermatologists, dermatologists, and allergists involved in the ongoing management of pediatric patients with moderate-to-severe atopic dermatitis.

Learning Objectives

After completing this activity, participants will be better prepared to:

  1. Evaluate pediatric patients with atopic dermatitis for disease severity, biopsychosocial burdens, comorbidities, and treatment responses
  2. Discuss the clinical profiles and latest trial evidence for current and emerging targeted therapies in pediatric patients with moderate-to-severe atopic dermatitis
  3. Construct treatment regimens for moderate-to-severe atopic dermatitis based on disease severity, comorbidities, and shared decision making with pediatric patients and their caregivers

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The UEMS-EACCME® and the AMA have recognized each other’s CME credits since 2000. In 2002 the UEMS-EACCME® and the AMA signed an agreement of mutual recognition of CME credits between Europe and the USA whereby European physicians attending an event in the USA have their credits recognized in Europe and American physicians attending an event in Europe have their credits recognized in the USA.

Royal College of Physicians and Surgeons of Canada

Activities held outside of Canada developed by a university, academy, specialty society, or other physician organization can be recorded as accredited group learning activities under Section 1 of the Royal College of Physician and Surgeons of Canada’s Maintenance of Certification (MOC) Program.

Japan Accreditation Council for Medical Education Credit

Activities certified by ACCME-accredited organizations may also allow Japanese learners to meet the criteria for Japan Accreditation Council for Medical Education credit.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the pretest, view the educational activity, score 75% or better on the posttest, and complete the program evaluation.

Disclosure of Conflicts of Interest

Global Education Group adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the ACCME and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global Education Group are required to disclose all financial relationships with any ineligible company within the past 24 months to Global Education Group. All financial relationships reported are identified as relevant and mitigated by Global Education Group in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global Education Group to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Jacob P. Thyssen, MD, PhD  Consulting fee:  AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Pharmaceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme; Contracted Research: Pfizer, Regeneron, Sanofi-Genzyme; Speaker Honoraria: AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme

The planners and managers have the following relevant financial relationships with ineligible companies:

Lindsay Borvansky: Nothing to disclose
Andrea Funk: Nothing to disclose
Liddy Knight: Nothing to disclose
Ashley Cann: Nothing to disclose
Stacey Ullman, MHS: Nothing to disclose
Rose O’Connor, PhD, CHCP: Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Integritas Communications do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Global Education Group Contact Information

For information about the accreditation of this program, please contact Global Education Group at 1-303-395-1782 or

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 0.50

credit type CME/CE

release 07/01/2022

expiration 07/01/2023